Further, estrogen potentially inhibits the beneficial effects of PPARα on obesity and lipid metabolism through its effects on PPARα-dependent gene regulation [95, 96]. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.